Normal labour - Nursing Case Study
Pathophysiology
• Primary mechanism: Hormonal regulation - The onset of normal labor is primarily driven by hormonal changes, particularly the increase in oxytocin and prostaglandins. These hormones stimulate uterine contractions by promoting calcium influx into muscle cells, leading to coordinated uterine activity essential for cervical dilation and fetal descent.
• Secondary mechanism: Cervical effacement and dilation - The cervix undergoes effacement (thinning) and dilation (opening) facilitated by uterine contractions and the pressure of the fetal head. This mechanical and biochemical transformation is crucial for allowing passage of the fetus through the birth canal.
• Key complication: Uterine atony - A potential complication post-delivery where the uterine muscle fails to contract effectively, leading to excessive bleeding (postpartum hemorrhage). Prompt recognition and management are vital to prevent maternal morbidity.
Patient Profile
Demographics:
27-year-old female, teacher
History:
• Key past medical history: Gestational diabetes in current pregnancy, no other significant medical history
• Current medications: Prenatal vitamins, insulin for gestational diabetes
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Onset of labor with contractions
• Key symptoms: Regular contractions every 5 minutes, moderate vaginal bleeding, reports of decreased fetal movement
• Vital signs: Blood pressure 145/95 mmHg, heart rate 110 bpm, temperature 37.8°C, respiratory rate 22 breaths per minute
Section 1
As the labor progresses, the nurse conducts an initial assessment to better understand the patient's current condition and guide further interventions. Upon examination, the nurse notes that the patient's cervix is 4 cm dilated and 80% effaced, indicating active labor; however, the moderate vaginal bleeding and reports of decreased fetal movement raise concerns. The fetal heart rate is assessed using external fetal monitoring and reveals a deceleration pattern, suggestive of potential fetal distress. The patient's blood pressure remains elevated at 148/97 mmHg, and her heart rate continues to be tachycardic at 115 bpm. Given these findings, the team considers the possibility of a placental abruption, especially in the context of gestational diabetes and hypertension, which can predispose the patient to such complications.
In response to these findings, the healthcare team orders an urgent ultrasound to assess the placental location and condition, as well as the amniotic fluid volume. Laboratory tests, including a complete blood count and coagulation profile, are also ordered to evaluate the patient's hematological status and rule out any underlying coagulopathy. Meanwhile, the patient is placed on continuous fetal monitoring, and oxygen is administered via a nasal cannula to optimize fetal oxygenation. An intravenous line is established to ensure rapid access for fluid administration and potential medication delivery.
The patient's clinical status requires close monitoring as the team evaluates the ultrasound and lab results. With the possibility of further complications such as uterine atony or severe fetal distress, the care plan remains adaptable, prepared for interventions ranging from enhanced monitoring and medical management to potential surgical delivery if the situation escalates. The healthcare team remains vigilant, balancing the need to promote vaginal delivery with the readiness to act swiftly should the patient's condition worsen, ensuring both maternal and fetal safety.
Section 2
As the healthcare team continues to monitor the patient, the urgent ultrasound results return, revealing a partial placental abruption. The ultrasound shows that while the placenta is still partially attached, there is significant disruption, which correlates with the moderate vaginal bleeding observed. The amniotic fluid volume is on the lower side of normal, which raises further concerns about fetal well-being. The lab results indicate mild anemia, with hemoglobin levels at 10.2 g/dL, and a slightly prolonged prothrombin time, suggesting the need for closer monitoring of coagulation status.
In response to these diagnostic findings, the healthcare team adjusts the care plan to prioritize both maternal stabilization and fetal well-being. The patient is started on a magnesium sulfate infusion to help manage her elevated blood pressure and reduce the risk of seizures associated with severe preeclampsia, a complication that is now being strongly considered. Continuous fetal monitoring continues to show variable decelerations, and though the fetal heart rate remains above 110 bpm, the pattern suggests intermittent cord compression, possibly exacerbated by the low amniotic fluid volume.
Given the partial abruption and the ongoing signs of fetal distress, the team deliberates the timing and method of delivery. The potential for a cesarean section is discussed with the patient and her family as the most definitive intervention to ensure fetal safety, given the current clinical picture. However, the team remains hopeful for a vaginal delivery if the patient's condition stabilizes with medical management. The plan involves a multidisciplinary approach, with obstetricians, anesthesiologists, and neonatologists on standby to provide comprehensive care as the situation evolves, ensuring that both maternal and fetal outcomes are optimized.
Section 3
As the healthcare team continues to monitor the patient's condition closely, the focus is on assessing her response to the ongoing interventions and identifying any new complications. The patient’s blood pressure remains elevated at 160/100 mmHg despite the magnesium sulfate infusion, indicating persistent hypertension. Her reflexes are brisk, and she reports a mild headache, further supporting the consideration of severe preeclampsia. The magnesium levels are checked to ensure they are within the therapeutic range, as toxicity could exacerbate her symptoms. The patient’s oxygen saturation is stable at 96% on room air, but she reports feeling increasingly fatigued, prompting the team to reassess her anemia management strategy.
Fetal monitoring continues to show variable decelerations, with a baseline fetal heart rate now fluctuating between 120-130 bpm, which, although reassuring, still presents concerns due to the repetitive nature of the decelerations. The decision to administer supplemental oxygen to the mother is made in an effort to enhance fetal oxygenation. The amniotic fluid index is checked again and shows a further decline, indicating oligohydramnios, which may worsen the cord compression and contribute to fetal distress.
With the partial placental abruption and ongoing fetal distress, the healthcare team must weigh the risks and benefits of continuing labor induction versus proceeding with a cesarean section. The patient expresses a desire for a vaginal delivery, but she is informed of the potential for rapid deterioration in both her condition and that of her baby. A repeat ultrasound and continuous fetal monitoring are ordered to guide the ongoing decision-making process. The team prepares for potential surgical intervention while continuing to optimize the patient's current management, ensuring that maternal and fetal safety remains the priority as they navigate these complications.
Section 4
As the healthcare team continues to monitor the patient and fetus closely, a change in the patient’s status becomes apparent. The patient's headache intensifies, and she begins to experience visual disturbances, such as seeing spots. These symptoms, coupled with her brisk reflexes and elevated blood pressure, suggest a potential progression towards eclampsia. The team conducts a thorough neurological assessment, noting the absence of clonus, but they remain vigilant for any signs of seizure activity. Her magnesium level is rechecked and found to be at the lower end of the therapeutic range, necessitating a slight increase in the infusion rate to maintain seizure prophylaxis. The patient's hemoglobin level, previously borderline, is now confirmed to be at 9.5 g/dL, indicating mild anemia, which could be contributing to her fatigue and overall sense of malaise.
In parallel, the fetal monitoring strips reveal more pronounced variable decelerations, with occasional late decelerations that raise concerns about fetal well-being. The baseline fetal heart rate remains within 120-130 bpm, but the non-reassuring patterns prompt the team to consider the implications of the declining amniotic fluid index, now measured at 4 cm, which further complicates the scenario. Recognizing the implications of oligohydramnios and the increased risk of cord compression, the team reassesses the labor plan. Despite the patient's desire for a vaginal delivery, the risk of fetal hypoxia and maternal complications prompts a discussion about the potential need for an expedited cesarean section.
The healthcare team collaborates closely with the patient and her family, emphasizing the critical balance between her preferences and the medical urgencies at play. A repeat ultrasound corroborates the findings of partial placental abruption, with an estimated fetal weight that suggests readiness for delivery. After a multidisciplinary team discussion, including obstetrics, anesthesia, and neonatology, the decision is made to proceed with a cesarean section, prioritizing the safety of both the mother and baby. Preparations are swiftly made, and the patient is counseled on the procedures and potential outcomes, ensuring she feels supported and informed as she transitions to the next phase of her care journey.
Section 5
As the patient is prepped for the cesarean section, the healthcare team remains vigilant, closely monitoring her vital signs and responding to any changes. Her blood pressure continues to be elevated, recorded at 160/100 mmHg, necessitating the administration of antihypertensive medication to mitigate the risk of complications during surgery. The magnesium infusion is adjusted to ensure it remains within the therapeutic range, with levels now at 2.0 mEq/L, providing reassurance against the immediate risk of seizures. Her reflexes are still brisk, but there is no clonus, and she remains responsive, although she expresses increased anxiety about the upcoming procedure.
Meanwhile, new diagnostic results from the laboratory provide additional insights into her condition. Her platelet count has decreased to 95,000/μL, raising concerns about potential coagulopathy, especially in the context of surgery. This finding prompts the anesthesia team to plan for potential blood product administration and to consider the safest anesthesia approach, taking into account her current hemodynamic status and the risk of bleeding. The patient's liver function tests remain within normal limits, providing some reassurance against the development of HELLP syndrome, yet the decrease in platelet count is carefully monitored.
The fetal heart rate monitoring continues to show variable decelerations, with the occasional late deceleration, confirming the need for the expedited delivery. The team remains coordinated and focused, with anesthesiologists, obstetricians, and neonatologists working in concert to ensure a safe delivery for both mother and baby. As the patient is escorted to the operating room, she is reassured and supported by the healthcare team, who have laid out a comprehensive plan to address any potential complications that might arise during the cesarean section. The anticipation of a positive outcome fuels the team's commitment to providing exceptional care as they prepare for the crucial next steps in the patient's journey.